Nextech Crossover I GP S.a r.l. 13D and 13G filings for Ambrx Biopharma Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-11-02 4:15 pm Purchase |
2023-11-01 | 13G | Ambrx Biopharma Inc. AMAM |
Nextech Crossover I GP S.a r.l. | 3,129,300 5.000% |
3,129,300 (New Position) |
Filing |